BioArctic AB (publ) (BIOA-B.ST)

SEK 170.0

(-0.93%)

Long Term Debt Summary of BioArctic AB (publ)

  • BioArctic AB (publ)'s latest annual long term debt in 2023 was 2.15 Million SEK , up 82.06% from previous year.
  • BioArctic AB (publ)'s latest quarterly long term debt in 2024 Q2 was 46.75 Million SEK , down 0.0% from previous quarter.
  • BioArctic AB (publ) reported annual long term debt of 1.18 Million SEK in 2022, down -84.82% from previous year.
  • BioArctic AB (publ) reported annual long term debt of 7.78 Million SEK in 2021, down -42.87% from previous year.
  • BioArctic AB (publ) reported quarterly long term debt of 2.38 Million SEK for 2024 Q1, down 0.0% from previous quarter.
  • BioArctic AB (publ) reported quarterly long term debt of 717 Thousand SEK for 2023 Q1, down -39.34% from previous quarter.

Annual Long Term Debt Chart of BioArctic AB (publ) (2023 - 2015)

Historical Annual Long Term Debt of BioArctic AB (publ) (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 2.15 Million SEK 82.06%
2022 1.18 Million SEK -84.82%
2021 7.78 Million SEK -42.87%
2020 13.62 Million SEK -34.88%
2019 20.92 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%

Peer Long Term Debt Comparison of BioArctic AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK 71.368%
Ziccum AB (publ) 286 Thousand SEK -652.448%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -153.176%
Genovis AB (publ.) 74.8 Million SEK 97.123%
Intervacc AB (publ) 142 Thousand SEK -1415.493%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 28.267%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 93.395%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 96.701%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 49.907%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -407.547%
Egetis Therapeutics AB (publ) 103.4 Million SEK 97.919%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -115.2%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.771%
Camurus AB (publ) 13.61 Million SEK 84.192%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 91.22%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.745%
Cyxone AB (publ) 74 Thousand SEK -2808.108%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -49.861%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 93.264%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -1482.353%
SynAct Pharma AB 58 Thousand SEK -3610.345%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -153.176%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -22.203%
BioInvent International AB (publ) 14.53 Million SEK 85.194%
Alzinova AB (publ) 800 Thousand SEK -169.0%
Oncopeptides AB (publ) 106.48 Million SEK 97.979%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 97.628%
Diamyd Medical AB (publ) 30.67 Million SEK 92.984%
Xbrane Biopharma AB (publ) 112.89 Million SEK 98.094%
Ascelia Pharma AB (publ) 176 Thousand SEK -1122.727%
Diagonal Bio AB (publ) - SEK -Infinity%